These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8227979)

  • 1. Effect of insulin treatment on osteocalcin levels in diabetic children and adolescents.
    Guarneri MP; Weber G; Gallia P; Chiumello G
    J Endocrinol Invest; 1993; 16(7):505-9. PubMed ID: 8227979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus.
    Lumachi F; Camozzi V; Tombolan V; Luisetto G
    Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E64-7. PubMed ID: 19751417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum osteocalcin levels in type I diabetes mellitus.
    Paşaoğlu H; Kumandaş S; Keleştimur F
    Turk J Pediatr; 1995; 37(4):323-9. PubMed ID: 8560599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin levels in diabetic subjects.
    Pedrazzoni M; Ciotti G; Pioli G; Girasole G; Davoli L; Palummeri E; Passeri M
    Calcif Tissue Int; 1989 Dec; 45(6):331-6. PubMed ID: 2804765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus.
    Wędrychowicz A; Stec M; Sztefko K; Starzyk JB
    Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):491-5. PubMed ID: 24918536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteocalcin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications.
    Pietschmann P; Schernthaner G; Woloszczuk W
    Diabetologia; 1988 Dec; 31(12):892-5. PubMed ID: 3266486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?
    Gregorio F; Cristallini S; Santeusanio F; Filipponi P; Fumelli P
    Diabetes Res Clin Pract; 1994 Feb; 23(1):43-54. PubMed ID: 8013262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes.
    Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
    Bone; 2016 Jan; 82():50-5. PubMed ID: 25888930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus.
    Bereket A; Lang CH; Blethen SL; Gelato MC; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1312-7. PubMed ID: 7536205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone calcium changes during diabetic ketoacidosis: a comparison with lactic acidosis due to volume depletion.
    Topaloglu AK; Yildizdas D; Yilmaz HL; Mungan NO; Yuksel B; Ozer G
    Bone; 2005 Jul; 37(1):122-7. PubMed ID: 15869925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pancreas transplantation on decreased levels of circulating bone gamma-carboxyglutamic acid-containing protein and osteopenia in rats with streptozotocin-induced diabetes.
    Ishida H; Seino Y; Takeshita N; Kurose T; Tsuji K; Okamoto Y; Someya Y; Hara K; Akiyama Y; Imura H
    Acta Endocrinol (Copenh); 1992 Jul; 127(1):81-5. PubMed ID: 1387756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low turnover bone disease in Egyptian children with acute leukemia.
    El-Ziny MA; Al-Tonbary YA; Salama OS; Bakr AA; Al-Marsafawy H; Elsharkawy AA
    Hematology; 2005 Aug; 10(4):327-33. PubMed ID: 16085546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.
    Tsentidis C; Gourgiotis D; Kossiva L; Marmarinos A; Doulgeraki A; Karavanaki K
    Pediatr Diabetes; 2016 Jun; 17(4):289-99. PubMed ID: 26094958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone may maintain bone formation in hibernating black bears (Ursus americanus) to prevent disuse osteoporosis.
    Donahue SW; Galley SA; Vaughan MR; Patterson-Buckendahl P; Demers LM; Vance JL; McGee ME
    J Exp Biol; 2006 May; 209(Pt 9):1630-8. PubMed ID: 16621944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
    Okten A; Cakir M; Makuloglu M
    Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.
    Mahdy KA; Ahmed HH; Mannaa F; Abdel-Shaheed A
    World J Gastroenterol; 2007 Feb; 13(5):785-90. PubMed ID: 17278204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.
    Wiernikowski JT; Barr RD; Webber C; Guo CY; Wright M; Atkinson SA
    J Oncol Pharm Pract; 2005 Jun; 11(2):51-6. PubMed ID: 16460605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
    Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
    Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.